A Pilot, Single-Center, Retrospective Case-Control Analysis To Identify Predictive Factors For Sustained Viral Response (SVR12) Failure Including Rapid Viral Response (RVR) In Patients With Hepatitis C Virus (HCV) Infection Receiving Ledipasvir and Sofosbuvir (LDV/SOF).

Trial Profile

A Pilot, Single-Center, Retrospective Case-Control Analysis To Identify Predictive Factors For Sustained Viral Response (SVR12) Failure Including Rapid Viral Response (RVR) In Patients With Hepatitis C Virus (HCV) Infection Receiving Ledipasvir and Sofosbuvir (LDV/SOF).

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Feb 2017

At a glance

  • Drugs Ledipasvir/sofosbuvir (Primary)
  • Indications Hepatitis C
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Feb 2017 Results assessing predictive factors for sustained viral response (SVR12) failure, published in the Annals of Pharmacotherapy.
    • 27 Dec 2016 New trial record
    • 30 Oct 2016 Results presented at the IDWeek 2016
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top